82 related articles for article (PubMed ID: 1669608)
1. [Osmotic resistance in erythrocytes in patients with chronic renal insufficiency].
Jakić M; Rupcić V; Stipanić S; Slanovic V
Lijec Vjesn; 1991; 113(11-12):398-401. PubMed ID: 1669608
[TBL] [Abstract][Full Text] [Related]
2. [Osmotic resistance in erythrocytes in patients with chronic kidney insufficiency].
Jakić M; Rupcić V; Stipanić S; Slanovic V
Lijec Vjesn; 1990; 112(9-10):284-7. PubMed ID: 2093782
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
[TBL] [Abstract][Full Text] [Related]
6. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
[TBL] [Abstract][Full Text] [Related]
7. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
8. Comparison of C-terminal and N-terminal PTH in secondary hyperparathyroidism in renal failure.
Hortling L; Puutula-Räsänen L; Fyhrquist F
Scand J Urol Nephrol Suppl; 1985; 90():51-4. PubMed ID: 3868028
[TBL] [Abstract][Full Text] [Related]
9. Effects of rHuEPO treatment on red blood cell osmotic resistance.
Mihaljević D; Jakić M; Jakić M; Cetina N; Wagner J; Zibar L; Barbić J
Coll Antropol; 2004 Dec; 28(2):639-46. PubMed ID: 15666595
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid sonography in secondary hyperparathyroidism: correlation with clinical findings.
Tomić Brzac H; Pavlović D; Halbauer M; Pasini J
Nephrol Dial Transplant; 1989; 4(1):45-50. PubMed ID: 2494598
[TBL] [Abstract][Full Text] [Related]
11. [Increased in vitro and ex vivo proliferation of erythroid precursors induced by calcitriol in chronic renal failure. Synergistic effect with rHuEPO].
Aucella F; Gatta G; Vigilante M; Scalzulli RP; Mantuano S; Carotenuto M; Stallone C
G Ital Nefrol; 2002; 19(2):137-42. PubMed ID: 12195411
[TBL] [Abstract][Full Text] [Related]
12. Does glucose in dialysis fluid protect erythrocytes in patients with chronic renal failure?
Dolegowska B; Stepniewska J; Ciechanowski K; Safranow K; Millo B; Bober J; Chlubek D
Blood Purif; 2007; 25(5-6):422-9. PubMed ID: 17938567
[TBL] [Abstract][Full Text] [Related]
13. [Parathyroid hormone and blood pressure in patients with chronic renal failure treated by repeated hemodialysis].
Starzyk J; Kowalski D; Kowalska K
Wiad Lek; 1989 Jan; 42(1):40-3. PubMed ID: 2781804
[TBL] [Abstract][Full Text] [Related]
14. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
Broulík P; Hrubý M
Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
[TBL] [Abstract][Full Text] [Related]
15. [Relation between serum levels of C-terminal fragment, beta 2 microglobulin and creatinine in patients with chronic nephropathies at different stages of the disease].
Kowalski D; Starzyk J; Kowalska K
Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1038-43. PubMed ID: 2700400
[TBL] [Abstract][Full Text] [Related]
16. Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease.
Monier-Faugere MC; Mawad H; Malluche HH
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1255-60. PubMed ID: 17942766
[TBL] [Abstract][Full Text] [Related]
17. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
Nasri H; Kheiri S
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
[TBL] [Abstract][Full Text] [Related]
18. Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
Docci D; del Vecchio C; Salvi P; Turci F; Salvi G; Cenciotti L; Pretolani E
Clin Nephrol; 1985 Feb; 23(2):68-73. PubMed ID: 3987101
[TBL] [Abstract][Full Text] [Related]
19. [Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure].
Starzyk J; Kowalski D
Wiad Lek; 1993 Apr; 46(7-8):283-5. PubMed ID: 8249416
[TBL] [Abstract][Full Text] [Related]
20. Red cell lipids in patients with end-stage renal failure: relationship to osmotic fragility.
Sasaki S
Osaka City Med J; 1977; 23(1):85-98. PubMed ID: 609453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
